AKTX stock has bullish potential due to its recent leadership change, with Samir Patel bringing extensive biotech expertise, which could drive strategic growth. The $7.6M raised in a private placement financing round demonstrates investor confidence and provides liquidity for ongoing operations. Current price levels may present an opportunity if Patel's leadership successfully enhances the company's pipeline and market position.